Table 1 Oncology drugs associated with stress cardiomyopathy
From: Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature
Oncology drug(s) | References |
|---|---|
5-Fluorouracil | Cheriparambil KM, et al. Angiology. 2000 [23] Dalzell JR, et al. Anticancer Drugs. 2009 [24] Gianni M, et al. Blood Coagul Fibrinolysis. 2009 [35] Kobayashi N, et al. J Nippon Med Sch. 2009 [21] Stewart T, et al. Intern Med J. 2010 [22] Basselin C, et al. Pharmacotherapy. 2011 [25] Radhakrishnan V, et al. J Pediatr Hematol Oncol. 2011 [19] Grunwald MR, et al. J Clin Oncol. 2012 [26] Ozturk MA, et al. Blood Coagul Fibrinolysis. 2013 [17] Knott K, et al. Int J Cardiol. 2014 [20] |
Capecitabine | Qasem, et al. Am J Ther. 2014 [27] Y-Hassan S, et al. Cardiovasc Revasc Med. 2013 [28] |
Cytarabine | Madias JE. Oncol Res Treat. 2015 [40] Baumann S, et al. Oncol Res Treat. 2014 [37] |
Cisplatin, docetaxel | Toyooka S, et al. Gen Thorac Cardiovasc Surg. 2012 [38] |
Cytarabine, daunorubicin | Goel S, et al.World J Clin Cases. 2014 [33] |
Paclitaxel, hydroxyurea, 5-Fluorouracil, concurrent radiation | Schweizer MT, et al. J Clin Oncol. 2011 [41] |
Axitinib | Ovadia D, et al. J Clin Oncol. 2015 [30] |
Sunitinib | Numico G, et al. J Clin Oncol. 2012 [39] |
Bevacizumab | Franco TH, et al. Ther Clin Risk Manag 2008 [31] |
Rituximab | Smith SA, et al. Heart Fail Clin. 2013 [15] Ng KH, et al. BMJ Case Rep. 2015 [32] |
Trastuzumab | Burgy M, et al. Anticancer Res. 2014 [42] Khanji M, et al. Clin Oncol (R Coll Radiol) 2013 [43] |
Cetuximab, irinotecan | Kim L, et al. J Invasive Cardiol. 2008 [29] |
Combretastatin | Bhakta S, et al. Clin Cardiol. 2009 [18] |